The 2023 UN high-level meeting on tuberculosis: renewing hope, momentum, and commitment to end tuberculosis
Year: 2023
Type: article
Abstract: Global efforts to end tuberculosis have saved an estimated 75 million lives this century. 1 The first UN General Assembly high-level meeting (HLM) on the fight against tuberculosis in 2018 was widely welcomed as a necessary reaffirmation of the commitments, defined in the WHO End TB Strategy and the UN Sustainable Development Goals, to end tuberculosis by 2030. 1,2 Despite this reaffirmation, only limited progress was made in tuberculosis prevention and care in the years following the 2018 HLM. Moreover, even this limited progress was decimated by the COVID-19 pandemic, which adversely affected access to tuberculosis services and financing, and intensified key social determinants of tuberculosis, including poverty and undernutrition. 3,4 In 2020, while scientific and health-care resources were ploughed into addressing COVID-19, it was estimated that 30 000 people developed tuberculosis disease and 4000 people died from tuberculosis every day. 2 Since then, tuberculosis has reclaimed from COVID-19 the unfortunate position of being the world's leading infectious killer, and drug-resistant tuberculosis has become a leading cause of death due to antimicrobial resistance. 5
Source: The Lancet Respiratory Medicine
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $6,300
Funders: Bill and Melinda Gates Foundation, World Health Organization, Wellcome Trust, Government of the United Kingdom, National Institute for Health and Care Research, Department for International Development, UK Government, Academy of Medical Sciences, Department for International Development, National Institutes of Health, Medical Research Council, Economic and Social Research Council, National Institute of Allergy and Infectious Diseases, Medical Research Foundation, European and Developing Countries Clinical Trials Partnership
Awards: G1303243219, Addressing the Social Determinants and Consequences of Tuberculosis (ASCOT): a pilot randomised controlled trial and process evaluation in Nepal, G1637947929, G1684583937, Improving scientific and public health decision making by developing technologies to increase use of robust methods to calibrate and analyse complex mathematical models, G2223609549, Infection prevention and control for drug-resistant tuberculosis in South Africa in the era of decentralised care: a whole systems approach, G242513792, G2660122252, G339059223, G361574396, Stichting Amsterdam Institute for Global Health and Development - to evaluate the extent to which Prevention of Mtb Infection is a surrogate for Prevention of TB Disease, Defining drivers of TB transmission in the era of universal ART, and implications for finding the walking well, TB-CAPS: a mixed methods study to implement a peer-led, community-based psychosocial support package for Indonesians affected by tuberculosis stigma, G5697490169, G6798766365, London School of Hygiene and Tropical Medicine - to support optimal funding and implementation of tuberculosis interventions coordinated through the tuberculosis modelling consortium (TB-MAC), Developing a locally-appropriate socioeconomic support package for TB-affected households in Nepal: a seed project to inform the END-TB trial
OpenAlex ID: W4388656753